Evolent Health, Inc. (EVH)
Evolent Health, Inc. (EVH) from its SEC filings: 2025 revenue $1.9 billion (-27% vs the year before), net margin -31%, free cash flow $38.8 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Services-Management Services |
| Revenue (2025) | $1.9 billion |
| Revenue growth | -27% |
| Net income | -$579.4 million |
| Net margin | -30.9% |
| Free cash flow | $38.8 million |
| Diluted EPS | $-5.07 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +47% |
| Cash | $115.7 million |
| Long-term debt | $966.5 million |
| Share count, 1 year | -4% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.